Volume 8 Number 4

Editorial

Lettres de noblesse: the three milestones

Serruys P

August 24, 2012 | 10.4244/EIJV8I4A63

In pursuit of perfection: “alive and better” as the measure of procedural success

Brennan JM

August 24, 2012 | 10.4244/EIJV8I4A64

Not all drug-eluting balloons are equally good for patients, not all patients are equally suitable for drug-eluting balloons

Cassese S, Kastrati A

August 24, 2012 | 10.4244/EIJV8I4A65

Multivessel versus culprit-only revascularisation in ST elevation acute myocardial infarction: facts and criticism

Kornowski R

August 24, 2012 | 10.4244/EIJV8I4A66

EAPCI column

The latest news about the ESCeL Platform

Fajadet J, Gonçalves L, Gilard M

August 24, 2012 | 10.4244/EIJV8I4A67

Clinical research

Quality of life improvement is maintained up to two years after transcatheter aortic valve implantation in high-risk surgical candidates

Taramasso M, Latib A, Cioni M, Denti P, Buzzatti N, Godino C, Chieffo A, Alfieri O, Colombo A, Maisano F

August 24, 2012 | 10.4244/EIJV8I4A68

Improvement of physical and mental health after transfemoral transcatheter aortic valve implantation

Stortecky S, Schmid V, Windecker S, Kadner A, Pilgrim T, Buellesfeld L, Khattab A, Wenaweser P

August 24, 2012 | 10.4244/EIJV8I4A69

Comparison of two drug-eluting balloons: a report from the SCAAR registry

Bondesson P, Lagerqvist B, James S, Olivecrona G, Venetsanos D, Harnek J

August 24, 2012 | 10.4244/EIJV8I4A70

Paclitaxel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study

Fischer D, Scheller B, Schäfer A, Klein G, Böhm M, Clever Y, Cremers B

August 24, 2012 | 10.4244/EIJV8I4A71

Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease

Okkels Jensen L, Thayssen P, Farkas D, Hougaard M, Terkelsen C, Tilsted H, Maeng M, Junker A, Flensted Lassen J, Horv E, Sørensen H, Thuesen L

August 24, 2012 | 10.4244/EIJV8I4A72

Contemporary use and outcome of percutaneous coronary interventions in patients with acute coronary syndromes: insights from the 2010 ACSIS and ACSIS-PCI surveys

Segev A, Matetzky S, Danenberg H, Fefer P, Bubyr L, Zahger D, Roguin A, Gottlieb S, Kornowski R

August 24, 2012 | 10.4244/EIJV8I4A73

De Luca G, Gibson C, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz H-R, Maioli M, Secco G, Zorman S, Gabriel H, Emre A, Rakowski T, van’t Hof A

August 24, 2012 | 10.4244/EIJV8I4A74

Optical coherence tomography assessment of the spatial distribution of culprit ruptured plaques and thin-cap fibroatheromas in acute coronary syndrome

Toutouzas K, Karanasos A, Riga M, Tsiamis E, Synetos A, Michelongona A, Papanikolaou A, Triantafyllou G, Tsioufis C, Stefanadis C

August 24, 2012 | 10.4244/EIJV8I4A75

Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study

Hamon M, Rao S, Steg G, Valgimigli M, Verheugt F, Marso S, Gershlick A, Wang Y, Deliargyris E

August 24, 2012 | 10.4244/EIJV8I4A76

Experimental research

Vasomotor function and re-endothelialisation after implantation of biodegradable abluminal polymer coated paclitaxel-eluting stents in rabbit iliac arteries: a time-course study

Nakamura T, Winsor-Hines D, Yin X, Sushkova N, Chen J, King III S, Chronos N, Eppihimer M, Huibregtse B, Dawkins K, Hou D

August 24, 2012 | 10.4244/EIJV8I4A77

Expert review

The transradial versus the transfemoral approach for primary percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis

Jang J, Jin H, Seo J, Yang T-H, Kim D-K, Kim D-K, Kim D-I, Cho K-I, Kim B-H, Park Y, Je H-G, Kim D-S

August 24, 2012 | 10.4244/EIJV8I4A78

Technical report

Non-invasive fractional flow reserve: scientific basis, methods and perspectives

Serruys P, Girasis C, Papadopoulou S-L, Onuma Y

August 24, 2012 | 10.4244/EIJV8I4A79

How should I treat?

How should I treat a retrograde dissection of the aortic sinus of Valsalva during a percutaneous coronary intervention?

Hung M-Y, Hung M-J

August 24, 2012 | 10.4244/EIJV8I4A80

Volume 8 Number 4

Editorial

EAPCI column

Clinical research

Experimental research

Expert review

Technical report

How should I treat?

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke